ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Behavioral Neurology Neuropsychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,088Medicare Part D Prescriptions Filled, Including Refills
$835K Total Retail Price of All Prescriptions
287 Patients Receiving at Least One Drug in Part D
17%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
BENZTROPINE MESYLATE 414 38 R
RISPERIDONE 358 58
CITALOPRAM HBR 322 115
VENLAFAXINE HCL ER 320 66
LITHIUM CARBONATE 314 22
TRAZODONE HCL 275 49
CLOZARIL 238 43 10
SERTRALINE HCL 236 33
DIVALPROEX SODIUM ER 235 56
LAMOTRIGINE 232 24
DIVALPROEX SODIUM 221 16
ABILIFY 218 0
CLOZAPINE 218 33
FLUOXETINE HCL 195 18
HALOPERIDOL 188 29
BUPROPION HCL SR 176 0
OLANZAPINE 142 19
SEROQUEL XR 141 37
BUPROPION XL 135 0
CYMBALTA 111 14
BUSPIRONE HCL 100 17
MIRTAZAPINE 97 45
ZIPRASIDONE HCL 97 0
ZOLPIDEM TARTRATE 93 11
PERPHENAZINE 91 33
ESCITALOPRAM OXALATE 89 15
NAMENDA 88 39
PAROXETINE HCL 88 0
PROPRANOLOL HCL 85 0
TRIHEXYPHENIDYL HCL 82 0 R
INVEGA 80 24
DONEPEZIL HCL 78 39
AMITRIPTYLINE HCL 76 54 R
LEVOTHYROXINE SODIUM 68 0
AMANTADINE 65 0
QUETIAPINE FUMARATE 65 0
TOPIRAMATE 52 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.